XML 18 R6.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Total
Common stock
Retained earnings
Accumulated other comprehensive income (loss)
Common stock shares outstanding, beginning balance (in shares) at Dec. 31, 2021   20,085,336    
Beginning balance at Dec. 31, 2021 $ 715,339 $ 249,856 $ 444,343 $ 21,140
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 19,951   19,951  
Share-based compensation expense 1,076 $ 1,076    
Common stock issued - Option exercise; stock grants (in shares)   104,840    
Common stock issued - Stock grants 0      
Other comprehensive income (loss) (52,069)     (52,069)
Dividends declared on common stock (7,164)   (7,164)  
Common stock repurchased (in shares)   (1,489,640)    
Common stock repurchased (75,902) $ (27,214) (48,688)  
Common stock shares outstanding, ending balance (in shares) at Mar. 31, 2022   18,700,536    
Ending balance at Mar. 31, 2022 $ 601,231 $ 223,718 408,442 (30,929)
Common stock shares outstanding, beginning balance (in shares) at Dec. 31, 2022 18,730,380 18,730,380    
Beginning balance at Dec. 31, 2022 $ 562,147 $ 226,592 435,085 (99,530)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 5,058   5,058  
Share-based compensation expense 1,016 $ 1,016    
Common stock issued - Option exercise; stock grants (in shares)   50,426    
Common stock issued - Stock grants 0      
Other comprehensive income (loss) 13,772     13,772
Dividends declared on common stock (6,684)   (6,684)  
Common stock repurchased (in shares)   (12,995)    
Common stock repurchased $ (315) $ (315)    
Common stock shares outstanding, ending balance (in shares) at Mar. 31, 2023 18,767,811 18,767,811    
Ending balance at Mar. 31, 2023 $ 574,994 $ 227,293 $ 433,459 $ (85,758)